Rachna Shah, MD
Allergy & Immunology · Melrose Park, ILNPI 1053592451
Payments from drug & device makers
Across 846 payments — averaging $1217.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$350K
- AstraZeneca$330K
- Regeneron$177K
- GSK$84K
- Teva Pharmaceuticals USA, Inc.$48K
- Mylan Specialty L.p.$32K
- plus $8K from 13 others
Across 8 payments — averaging $140.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 42 | $349,942 |
| AstraZeneca | 14 | $330,353 |
| Regeneron | 647 | $177,179 |
| GSK | 56 | $84,023 |
| Teva Pharmaceuticals USA, Inc. | 4 | $48,360 |
| Mylan Specialty L.p. | 8 | $32,178 |
| Cipla USA Inc. | 11 | $2,480 |
| Pfizer | 6 | $2,264 |
| Boehringer Ingelheim | 1 | $2,000 |
| Sanofi | 29 | $511 |
| Regeneron Healthcare Solutions, Inc. | 14 | $362 |
| Sanofi-aventis U.S. LLC | 1 | $90 |
| Biocryst US Sales Co., LLC | 3 | $51 |
| Eyevance Pharmaceuticals LLC | 3 | $49 |
| Amgen | 2 | $41 |
| Lilly USA, LLC | 1 | $35 |
| Genentech USA, Inc. | 2 | $28 |
| Galderma Laboratories, L.p. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
How this compares
$1,029,980 in reported general payments places this provider in the 95th percentile of 161 allergy & immunology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Melrose Park
- Dareen SiriNormal$5.9M
- Giselle MosnaimChicago$2.2M
- Anju PetersChicago$2.1M
- Priya BansalSaint Charles$1.3M
- Melanie MakhijaChicago$402K
- Elizabeth LippnerChicago$329K
- Patrick WinShiloh$314K
- Christina CiaccioChicago$310K
- Amanda SalihChicago$160K
- Rebecca HoffmanWilmette$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.